OVERVIEW

Seventh Annual Clinical Advances in Heart Failure and Arrhythmias is organized by Scripps Conference Services & CME and will be held on Nov 14, 2020.

Accreditation:
Physicians
Scripps Health designates this live internet activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Assistants
PAs may claim a maximum of 4 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Description:
Significant advances in the diagnosis and management of heart failure and arrhythmias continue to emerge, compelling the practice of cardiology to constantly evolve. These advances must be consistently implemented into clinical practice to guarantee the best care for patients affected by these cardiovascular conditions. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient outcomes.

Educational Objectives:
After attending this live internet activity, participants should be able to:
• Incorporate current and emerging clinical evidence in the assessment, treatment and management of patients with challenging cardiovascular disease.
• Apply new concepts in the management of arrhythmias, heart failure and hypertension.
• Employ new medical and surgical therapies for heart failure.
• Discuss current pharmacologic and medical management strategies for patients with atrial fibrillation.
• Assess device-based therapies for heart rhythm disorders.